Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16459665rdf:typepubmed:Citationlld:pubmed
pubmed-article:16459665lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:16459665lifeskim:mentionsumls-concept:C0162791lld:lifeskim
pubmed-article:16459665lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:16459665lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:16459665pubmed:issue4lld:pubmed
pubmed-article:16459665pubmed:dateCreated2006-2-7lld:pubmed
pubmed-article:16459665pubmed:abstractTextThe follow-up of urothelial tumours is designed to allow early detection of recurrence or progression, for which treatment is possible. Recent interesting points are: the more frequent and simpler use of the new classification into low grade and high grade, essentially applied to the management and surveillance of tumours involving the mucosa or lamina propria; and the limited place of urinary markers.lld:pubmed
pubmed-article:16459665pubmed:languagefrelld:pubmed
pubmed-article:16459665pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16459665pubmed:citationSubsetIMlld:pubmed
pubmed-article:16459665pubmed:statusMEDLINElld:pubmed
pubmed-article:16459665pubmed:monthSeplld:pubmed
pubmed-article:16459665pubmed:issn1166-7087lld:pubmed
pubmed-article:16459665pubmed:authorpubmed-author:DavinJean-Lou...lld:pubmed
pubmed-article:16459665pubmed:authorpubmed-author:LebretThierry...lld:pubmed
pubmed-article:16459665pubmed:authorpubmed-author:IraniJacquesJlld:pubmed
pubmed-article:16459665pubmed:authorpubmed-author:TheodoreChris...lld:pubmed
pubmed-article:16459665pubmed:authorpubmed-author:Comité de...lld:pubmed
pubmed-article:16459665pubmed:issnTypePrintlld:pubmed
pubmed-article:16459665pubmed:volume15lld:pubmed
pubmed-article:16459665pubmed:ownerNLMlld:pubmed
pubmed-article:16459665pubmed:authorsCompleteYlld:pubmed
pubmed-article:16459665pubmed:pagination581-6lld:pubmed
pubmed-article:16459665pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16459665pubmed:meshHeadingpubmed-meshheading:16459665...lld:pubmed
pubmed-article:16459665pubmed:meshHeadingpubmed-meshheading:16459665...lld:pubmed
pubmed-article:16459665pubmed:meshHeadingpubmed-meshheading:16459665...lld:pubmed
pubmed-article:16459665pubmed:meshHeadingpubmed-meshheading:16459665...lld:pubmed
pubmed-article:16459665pubmed:meshHeadingpubmed-meshheading:16459665...lld:pubmed
pubmed-article:16459665pubmed:meshHeadingpubmed-meshheading:16459665...lld:pubmed
pubmed-article:16459665pubmed:year2005lld:pubmed
pubmed-article:16459665pubmed:articleTitle[Follow-up of urothelial tumours. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie].lld:pubmed
pubmed-article:16459665pubmed:affiliationComite Tumeurs Urothéliales du CCAFU. j.irani@chu-poitiers.frlld:pubmed
pubmed-article:16459665pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16459665pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:16459665pubmed:publicationTypeReviewlld:pubmed
pubmed-article:16459665pubmed:publicationTypePractice Guidelinelld:pubmed